19 results on '"Piva, F"'
Search Results
2. Degradation mechanisms of InGaN visible LEDs and AlGaN UV LEDs
- Author
-
De Santi, C., primary, Caria, A., additional, Piva, F., additional, Meneghesso, G., additional, Zanoni, E., additional, and Meneghini, M., additional
- Published
- 2021
- Full Text
- View/download PDF
3. ROLE OF THE AMYGDALA AND THE ORGANUM VASCULOSUM LAMINAE TERMINALIS IN THE CONTROL OF OVARIAN FUNCTION IN THE FEMALE RAT
- Author
-
PIVA, F., primary, BORRELL, J., additional, LIMONTA, P., additional, GAVAZZI, G., additional, and MARTINI, L., additional
- Published
- 1979
- Full Text
- View/download PDF
4. NEUROHUMORAL FACTORS CONTROLLING GONADOTROPIN SECRETION
- Author
-
Borrell, J., primary, Piva, F., additional, and Martini, L., additional
- Published
- 1976
- Full Text
- View/download PDF
5. The Role of “Short” Feedback Mechanisms in the Regulation of Adrenocorticotropin Secretion
- Author
-
Motta, M., primary, Piva, F., additional, and Martini, L., additional
- Published
- 1970
- Full Text
- View/download PDF
6. Effects of extremely low-frequency magnetic fields on human MDA-MB-231 breast cancer cells: proteomic characterization.
- Author
-
Lazzarini R, Eléxpuru-Zabaleta M, Piva F, Giulietti M, Fulgenzi G, Tartaglione MF, Zingaretti L, Tagliabracci A, Valentino M, Santarelli L, and Bracci M
- Subjects
- Humans, Female, Proteomics, Magnetic Fields, Electromagnetic Fields adverse effects, Oxidative Stress, Breast Neoplasms
- Abstract
Extremely low-frequency electromagnetic fields (ELF-MF) can modify the cell viability and regulatory processes of some cell types, including breast cancer cells. Breast cancer is a multifactorial disease where a role for ELF-MF cannot be excluded. ELF-MF may influence the biological properties of breast cells through molecular mechanisms and signaling pathways that are still unclear. This study analyzed the changes in the cell viability, cellular morphology, oxidative stress response and alteration of proteomic profile in breast cancer cells (MDA-MB-231) exposed to ELF-MF (50 Hz, 1 mT for 4 h). Non-tumorigenic human breast cells (MCF-10A) were used as control cells. Exposed MDA-MB-231 breast cancer cells increased their viability and live cell number and showed a higher density and length of filopodia compared with the unexposed cells. In addition, ELF-MF induced an increase of the mitochondrial ROS levels and an alteration of mitochondrial morphology. Proteomic data analysis showed that ELF-MF altered the expression of 328 proteins in MDA-MB-231 cells and of 242 proteins in MCF-10A cells. Gene Ontology term enrichment analysis demonstrated that in both cell lines ELF-MF exposure up-regulated the genes enriched in "focal adhesion" and "mitochondrion". The ELF-MF exposure decreased the adhesive properties of MDA-MB-231 cells and increased the migration and invasion cell abilities. At the same time, proteomic analysis, confirmed by Real Time PCR, revealed that transcription factors associated with cellular reprogramming were upregulated in MDA-MB-231 cells and downregulated in MCF-10A cells after ELF-MF exposure. MDA-MB-231 breast cancer cells exposed to 1 mT 50 Hz ELF-MF showed modifications in proteomic profile together with changes in cell viability, cellular morphology, oxidative stress response, adhesion, migration and invasion cell abilities. The main signaling pathways involved were relative to focal adhesion, mitochondrion and cellular reprogramming., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
7. Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States.
- Author
-
Santoni M, Piva F, Porta C, Bracarda S, Heng DY, Matrana MR, Grande E, Mollica V, Aurilio G, Rizzo M, Giulietti M, Montironi R, and Massari F
- Subjects
- Humans, Incidence, Neural Networks, Computer, Risk Factors, Smoking, United States epidemiology, Carcinoma, Renal Cell epidemiology, Kidney Neoplasms epidemiology
- Abstract
Introduction: The incidence of kidney cancer is increasing; it could be counteracted with new ways to predict and detect it. We aimed to implement an artificial neural network in order to predict new cases of renal-cell carcinoma (RCC) in the population using population rate, obesity, smoking incidence, uncontrolled hypertension, and life expectancy data in the United States., Patients and Methods: Statistics were collected on US population numbers, life expectancy, obesity, smoking, and hypertension. We used MATLAB R2018 (MathWorks) software to implement an artificial neural network. Data were repeatedly and randomly divided into training (70%) and validation (30%) subsets., Results: The number of new RCC cases will grow from 44,400 (2020) to 55,400 (2050), an increase of +24.7%. Our data show that preventing hypertension would have the greatest impact on reduction of the incidence, estimated at -775 and -575 cases per year in 2020 and in 2030, respectively. The prevention of obesity and smoking would have a more limited impact, estimated at -64 and -180 cases per year in 2020 and in 2030, respectively, for obesity, and -173 and -21 cases per year in 2020 and in 2030, respectively, for smoking., Conclusions: Our predictions underline the need for accurate studies on RCC-related risk factors to reduce the incidence., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
8. Metabolic phenotype of bladder cancer.
- Author
-
Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R, Tortora G, Lopez-Beltran A, Cheng L, and Montironi R
- Subjects
- Cell Proliferation physiology, Gene Expression Regulation, Neoplastic physiology, Glucose Transporter Type 1 metabolism, Glycine Hydroxymethyltransferase genetics, Humans, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Proto-Oncogene Proteins c-akt metabolism, Transcriptional Activation, Carcinogenesis genetics, Carcinogenesis metabolism, Glucose metabolism, Glycolysis genetics, Urinary Bladder Neoplasms genetics, Urinary Bladder Neoplasms metabolism
- Abstract
Metabolism of bladder cancer represents a key issue for cancer research. Several metabolic altered pathways are involved in bladder tumorigenesis, representing therefore interesting targets for therapy. Tumor cells, including urothelial cancer cells, rely on a peculiar shift to aerobic glycolysis-dependent metabolism (the Warburg-effect) as the main energy source to sustain their uncontrolled growth and proliferation. Therefore, the high glycolytic flux depends on the overexpression of glycolysis-related genes (SRC-3, glucose transporter type 1 [GLUT1], GLUT3, lactic dehydrogenase A [LDHA], LDHB, hexokinase 1 [HK1], HK2, pyruvate kinase type M [PKM], and hypoxia-inducible factor 1-alpha [HIF-1α]), resulting in an overproduction of pyruvate, alanine and lactate. Concurrently, bladder cancer metabolism displays an increased expression of genes favoring the pentose phosphate pathway (glucose-6-phosphate dehydrogenase [G6PD]) and the fatty-acid synthesis (fatty acid synthase [FASN]), along with a decrease of AMP-activated protein kinase (AMPK) and Krebs cycle activities. Moreover, the PTEN/PI3K/AKT/mTOR pathway, hyper-activated in bladder cancer, acts as central regulator of aerobic glycolysis, hence contributing to cancer metabolic switch and tumor cell proliferation. Besides glycolysis, glycogen metabolism pathway plays a robust role in bladder cancer development. In particular, the overexpression of GLUT-1, the loss of the tumor suppressor glycogen debranching enzyme amylo-α-1,6-glucosidase, 4-α-glucanotransferase (AGL), and the increased activity of the tumor promoter enzyme glycogen phosphorylase impair glycogen metabolism. An increase in glucose uptake, decrease in normal cellular glycogen storage, and overproduction of lactate are consequences of decreased oxidative phosphorylation and inability to reuse glucose into the pentose phosphate and de novo fatty acid synthesis pathways. Moreover, AGL loss determines augmented levels of the serine-to-glycine enzyme serine hydroxymethyltransferase-2 (SHMT2), resulting in an increased glycine and purine ring of nucleotides synthesis, thus supporting cells proliferation. A deep understanding of the metabolic phenotype of bladder cancer will provide novel opportunities for targeted therapeutic strategies., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
9. Metabolic alterations in renal cell carcinoma.
- Author
-
Massari F, Ciccarese C, Santoni M, Brunelli M, Piva F, Modena A, Bimbatti D, Fantinel E, Santini D, Cheng L, Cascinu S, Montironi R, and Tortora G
- Subjects
- Animals, Humans, Metabolic Networks and Pathways, Carcinoma, Renal Cell metabolism, Kidney Neoplasms metabolism
- Abstract
Renal cell carcinoma (RCC) is a metabolic disease, being characterized by the dysregulation of metabolic pathways involved in oxygen sensing (VHL/HIF pathway alterations and the subsequent up-regulation of HIF-responsive genes such as VEGF, PDGF, EGF, and glucose transporters GLUT1 and GLUT4, which justify the RCC reliance on aerobic glycolysis), energy sensing (fumarate hydratase-deficient, succinate dehydrogenase-deficient RCC, mutations of HGF/MET pathway resulting in the metabolic Warburg shift marked by RCC increased dependence on aerobic glycolysis and the pentose phosphate shunt, augmented lipogenesis, and reduced AMPK and Krebs cycle activity) and/or nutrient sensing cascade (deregulation of AMPK-TSC1/2-mTOR and PI3K-Akt-mTOR pathways). We analyzed the key metabolic abnormalities underlying RCC carcinogenesis, highlighting those altered pathways that may represent potential targets for the development of more effective therapeutic strategies., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
10. Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target.
- Author
-
Santoni M, Andrikou K, Sotte V, Bittoni A, Lanese A, Pellei C, Piva F, Conti A, Nabissi M, Santoni G, and Cascinu S
- Subjects
- Humans, Signal Transduction, Pancreatic Diseases pathology, Pancreatic Diseases therapy, Toll-Like Receptors metabolism
- Abstract
Toll-like receptors (TLRs) mediate interactions between environmental stimuli and innate immunity. TLRs play a major role in the development of numerous pancreatic diseases, making these molecules attractive as potential therapeutic targets. TLR2, TLR7 and TLR9 are involved in the initiation of type 1 diabetes mellitus (T1DM), whereas TLR2 and TLR4 play a major role in the onset of type 2 diabetes mellitus (T2DM). Furthermore, TLRs cause derangements in several tumor suppressor proteins (such as p16, p21, p27, p53 and pRb), induce STAT3 activation and promote epithelial-mesenchymal transition as well as oncogene-induced senescence. In this review we will focus on the contribution of TLRs in pancreatic disease including cancer and we describe recent progress in TLR-modulation for the treatment of these patients., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
11. PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.
- Author
-
Massari F, Santoni M, Ciccarese C, Santini D, Alfieri S, Martignoni G, Brunelli M, Piva F, Berardi R, Montironi R, Porta C, Cascinu S, and Tortora G
- Subjects
- Antibodies, Monoclonal therapeutic use, Antibodies, Monoclonal, Humanized therapeutic use, Antibody-Dependent Cell Cytotoxicity drug effects, Antineoplastic Agents immunology, Antineoplastic Agents pharmacology, B7-H1 Antigen metabolism, Carcinoma, Renal Cell immunology, Carcinoma, Renal Cell pathology, Cell Proliferation drug effects, Clinical Trials as Topic, Down-Regulation, Gene Expression Regulation, Neoplastic, Humans, Ipilimumab, Kidney Neoplasms immunology, Kidney Neoplasms pathology, Neoplasm Grading, Neoplasm Staging, Nivolumab, Prognosis, Programmed Cell Death 1 Receptor metabolism, Receptors, Vascular Endothelial Growth Factor antagonists & inhibitors, T-Lymphocytes drug effects, Vascular Endothelial Growth Factor A antagonists & inhibitors, Antineoplastic Agents therapeutic use, B7-H1 Antigen antagonists & inhibitors, Carcinoma, Renal Cell drug therapy, Immunotherapy methods, Kidney Neoplasms drug therapy, Programmed Cell Death 1 Receptor antagonists & inhibitors, Signal Transduction drug effects, T-Lymphocytes immunology
- Abstract
RCC is considered an immunogenic tumor with a prominent dysfunctional immune cell infiltrate, unable to control tumor growth. Evasion of immune surveillance, a process defined immune-editing, leads to malignant progression. The striking improvement of knowledge in immunology has led to the identification of immune checkpoints (such as CTLA-4 and PD-1), whose blockage enhances the antitumor immunity. The interaction between PD-1, an inducible inhibitory receptor expressed on lymphocytes and DCs, and PD-L1 ligand, expressed by tumor cells, results in a down-regulation of the T-cell response. Therefore, the PD-1/PD-L1 axis inhibition by targeted-antibodies, increasing the T-cell proliferation and cytotoxicity, represents a promising mechanism to stimulate the anti-tumor activity of the immune system, improving the outcomes of cancer patients. Several PD-1 and PD-L1 inhibitors have been evaluated in different tumor types, showing promising results. The interesting correlation between lymphocytes PD-1 expression and RCC advanced stage, grade and prognosis, as well as the selective PD-L1 expression by RCC tumor cells and its potential association with worse clinical outcomes, have led to the development of new anti PD-1/PD-L1 agents, alone or in combination with anti-angiogenic drugs or other immunotherapeutic approaches, for the treatment of RCC. In this review we discuss the role of PD-1/PD-L1 in RCC, focusing on the biological rationale, current clinical studies and promising therapeutic perspectives to target the PD-1 pathway., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
12. Effects and metabolism of steroid hormones in human neuroblastoma cells.
- Author
-
Maggi R, Poletti A, Casulari LA, Pimpinelli F, Piva F, Zanisi MR, and Martini L
- Subjects
- Cell Division drug effects, Cell Division physiology, Central Nervous System cytology, Central Nervous System drug effects, Humans, Neuroblastoma metabolism, Neuroblastoma pathology, Tumor Cells, Cultured, Central Nervous System metabolism, Progesterone physiology, Testosterone physiology
- Abstract
The development of the central nervous system is influenced by sex steroids and by their metabolites. However, little information on the possible effects of steroid hormones on neuroblastoma cells is available. Human neuroblastoma cell lines have been used as a model of human neuroblasts in vitro to study the metabolism of steroid hormones; in addition, the effects of steroids and steroid antagonists on neuroblastoma cell growth have also been investigated. The results obtained show that SH-SY5Y human neuroblastoma cells may actively metabolize testosterone and progesterone to their respective 5 alpha-reduced metabolites and that differentiation of neuroblastoma cells is paralleled by a significant increase in expression of the type-1 5 alpha-reductase and of the formation of steroid metabolites. All these data are suggestive of a potential role of steroid 5 alpha-reduced metabolites in the biology of neuroblastoma cells. Studies performed to analyze the role of steroid hormones on neuroblastoma cell proliferation show that progesterone at low doses may induce minor stimulation, and at higher doses, a toxic effect on the neuroblastoma cell line SK-N-SH is seen. Moreover, the antiprogestin 17 beta-hydroxy-11 beta-(4-dimethylamino-phenyl-1)-17-(prop-1-ynyl)estra-4,9-dien+ ++-3-one (RU486) decreases the proliferation of these cells in a dose-dependent manner. The effect of RU486 is not antagonized by either progesterone or dexamethasone, a result that seems to exclude the action of RU486 via classic intracellular steroid hormone receptors.
- Published
- 1998
- Full Text
- View/download PDF
13. Effect of aging on opioid and LHRH receptors in the brain, pituitary, and testis of the male rat.
- Author
-
Piva F, Limonta P, Maggi R, Dondi D, Messi E, Zanisi M, and Martini L
- Subjects
- Animals, Brain Chemistry drug effects, Estrus physiology, Female, Hypothalamus metabolism, Hypothalamus physiology, Male, Pituitary Gland drug effects, Pituitary Gland, Anterior metabolism, Pituitary Gland, Anterior physiology, Rats, Receptors, LHRH drug effects, Receptors, Opioid drug effects, Testis drug effects, Aging physiology, Brain Chemistry physiology, Pituitary Gland metabolism, Receptors, LHRH physiology, Receptors, Opioid physiology, Testis metabolism
- Published
- 1994
- Full Text
- View/download PDF
14. Decrease of mu opioid receptors in the brain and in the hypothalamus of the aged male rat.
- Author
-
Piva F, Maggi R, Limonta P, Dondi D, and Martini L
- Subjects
- Animals, Male, Radioimmunoassay, Rats, Rats, Inbred Strains, Receptors, Opioid, mu, Testosterone blood, Aging metabolism, Brain metabolism, Hypothalamus metabolism, Receptors, Opioid metabolism
- Abstract
Experiments have been designed in order to analyze whether the binding capability of mu opioid receptors in the brain of the male rat is modified by age. In a first experiment, the number of receptors (Bmax) and the constant of affinity (Ka) for the mu ligand 3H-dihydromorphine (3H-DHM) have been measured in the whole brain of male rats of 2, 15 and 22 months of age. In a second experiment the Bmax and the Ka for 3H-DHM have been evaluated in the hypothalamus of male rats of 2 and 22 months of age. In this experiment it was also investigated whether the administration of exogenous testosterone modifies the number and/or the affinity of the hypothalamic mu receptors. Serum levels of LH, FSH, prolactin and testosterone have been measured by specific RIAs. The results obtained show that: serum testosterone levels are significantly decreased in aged rats, while serum LH and FSH show only a small decline; serum prolactin is higher in old than in young animals; the number of mu receptors in the whole brain of 15 and 22 month old animals and in the hypothalamus of 22 month old rats is significantly lower than in the same tissues of young animals; the administration to old animals of testosterone, in doses able to bring back towards normal serum levels of testosterone, induces a decrease of LH and FSH, but has no effect on serum prolactin titers. Testosterone administration does not modify the number of hypothalamic mu opioid receptors, indicating that the decline of brain mu receptors in old animals is not the consequence of the physiological decline of testosterone secretion; in no instance the Ka for the mu ligand is significantly affected.
- Published
- 1987
- Full Text
- View/download PDF
15. Effect of ovarian steroids on the concentration of mu opiate receptors in different regions of the brain of the female rat.
- Author
-
Maggi R, Limonta P, Dondi D, and Piva F
- Subjects
- Animals, Brain drug effects, Brain Chemistry, Estradiol pharmacology, Female, Luteinizing Hormone blood, Luteinizing Hormone metabolism, Ovariectomy, Rats, Receptors, Opioid drug effects, Receptors, Opioid, mu, Brain metabolism, Ovary metabolism, Receptors, Opioid metabolism, Steroids metabolism
- Published
- 1989
- Full Text
- View/download PDF
16. [Alveolar macrophages and antibiotics. Review].
- Author
-
Voisin C, Carré P, Piva F, and Wallaert B
- Subjects
- Animals, Bacteria drug effects, Humans, Macrophages cytology, Macrophages immunology, Phagocytosis drug effects, Rats, Anti-Bacterial Agents pharmacology, Macrophages drug effects, Pulmonary Alveoli cytology
- Abstract
Although alveolar macrophages play a key role in pulmonary defence against infections, little is known about interactions of these cells with antibiotics. In vitro, some drugs fail to enter alveolar macrophages readily; in contrast, other antimicrobial agents (clindamycin, erythromycin, ethambutol) are highly concentrated by these cells, as well as josamycin, erythromycin and spiramycin in vivo. Moreover, clindamycin, erythromycin, chloramphenicol, rifampin and pefloxacin lead to an increased phagocytosis by alveolar macrophages, either by compromising bacterial antiphagocytic components or stimulating proper phagocytic activity of the cell. The influence of antibiotics upon mechanisms of microorganisms destruction (production of oxygen metabolites, oxygen independent system), upon regulation of lymphocyte functions (interleukin 1, prostaglandin E2) or other secretory activities (enzymes, modulators of cell activities, various bioactive products) have not been extensively studied and require further investigations.
- Published
- 1987
17. Distribution of kappa opioid receptors in the brain of young and old male rats.
- Author
-
Maggi R, Limonta P, Dondi D, Martini L, and Piva F
- Subjects
- Aging physiology, Amygdala physiology, Animals, Brain Chemistry, Fluorescent Antibody Technique, Male, Rats, Rats, Inbred Strains, Receptors, Opioid, kappa, Brain physiology, Receptors, Opioid physiology
- Abstract
The experiments to be described have been designed in order to: (a) provide new information on the concentrations of opioid kappa receptors in different regions of the brain of the male rats; and (b) to analyze whether the density of brain kappa receptors might be modified by the process of aging. The concentration of kappa receptors was investigated in the hypothalamus, amygdala, mesencephalon, corpus striatum, hippocampus, thalamus, frontal poles, anterior and posterior cortex collected from male rats of 2 and 19 months of age. 3H-bremazocine (BRZ) was used as the ligand of kappa receptors, after protection of mu and delta receptors respectively with dihydromorphine and d-ala-d-leu-enkephalin. The results obtained show that: (1) in young male rats, the number of kappa opioid receptors is different in the various brain areas examined: the hypothalamus and the striatum have a concentration of kappa binding sites which is significantly higher than that found in the mesencephalon and in the amygdala; much lower concentrations of kappa binding sites have been found in the thalamus, the frontal poles, the hippocampus, the anterior and posterior cerebral cortex. (2) Aging exerts little influence on the number of kappa receptors in the majority of the brain structures considered. However in the amygdala and in the thalamus the number of kappa receptors was increased in old animals. To the authors' knowledge, the data here presented are the first ones which suggest that age may increase rather than decrease the number of neurotransmitter receptors in the brain.
- Published
- 1989
- Full Text
- View/download PDF
18. Effects of aging on pituitary and testicular luteinizing hormone-releasing hormone receptors in the rat.
- Author
-
Limonta P, Dondi D, Maggi R, Martini L, and Piva F
- Subjects
- Animals, Luteinizing Hormone blood, Male, Rats, Rats, Inbred Strains, Testosterone blood, Aging metabolism, Pituitary Gland metabolism, Receptors, LH metabolism, Testis metabolism
- Abstract
Aging exerts profound influences on the function of the hypothalamic-pituitary-testicular-axis. This work has been performed in order to verify whether, in male rats, the decreased secretion of LH and testosterone (T) occurring in old animals is reflected by modifications of luteinizing hormone-releasing hormone (LHRH) receptors at the level of the anterior pituitary and of the testes. To this purpose, the affinity constant (Ka) and the maximal binding capacity (Bmax) for the LHRH analog [D-Ser(tBu)6]des-Gly10-LHRH-N-ethylamide were evaluated, by means of a receptor binding assay, in membrane preparations derived from the anterior pituitary and testicular Leydig cells of male rats of 3 and 19 months of age. Serum levels of LH and T were measured by specific RIAs. The results obtained show that, in aged male rats, the concentration of pituitary LHRH receptors is significantly lower than that found in young animals. On the other hand, the concentration of LHRH binding sites is significantly increased on the membranes of Leydig cells of old rats. In no instance the Ka for the LHRH analog is significantly affected. Serum levels of LH and T are significantly lower in old than in young male rats. In conclusion, these results suggest that the reduced secretion of LH in old male rats may be linked, at least partially, to a decrease of the number of pituitary LHRH receptors. The impaired production of testosterone occurring in aged rats is accompanied by a significant increase of the number of testicular LHRH receptors, indicating that also the intratesticular mechanisms controlling testosterone release undergo significant alterations with aging.
- Published
- 1988
- Full Text
- View/download PDF
19. The role of "short" feedback mechanisms in the regulation of adrenocorticotropin secretion.
- Author
-
Motta M, Piva F, and Martini L
- Subjects
- Adrenocorticotropic Hormone pharmacology, Animals, Cerebral Cortex drug effects, Hypothalamus drug effects, Male, Pituitary Gland drug effects, Rats, Receptors, Drug, Adrenocorticotropic Hormone metabolism, Feedback
- Published
- 1970
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.